{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T10:57:26Z","timestamp":1773572246663,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cca.2021.10.011","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T13:58:40Z","timestamp":1634565520000},"page":"397-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Determination of 97.5th and 99th percentile upper reference limits for heart-type fatty acid-binding protein (H-FABP) in a US population"],"prefix":"10.1016","volume":"523","author":[{"given":"Michael A.","family":"Vera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Kavsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe M.","family":"El-Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2021.10.011_b0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2017.09.007","article-title":"Heart-type fatty acid-binding protein in cardiovascular disease: A systemic review","volume":"474","author":"Otaki","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2021.10.011_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(88)90141-5","article-title":"Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox","volume":"961","author":"Glatz","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2021.10.011_b0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clinbiochem.2018.05.006","article-title":"The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations","volume":"58","author":"Kavsak","year":"2018","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.cca.2021.10.011_b0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajem.2010.11.022","article-title":"Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction","volume":"30","author":"McMahon","year":"2012","journal-title":"Am. J. Emerg. Med."},{"issue":"10212","key":"10.1016\/j.cca.2021.10.011_b0025","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cca.2021.10.011_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-017-0487-8","article-title":"Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria","volume":"18","author":"Koeze","year":"2017","journal-title":"BMC Nephrol."},{"issue":"12","key":"10.1016\/j.cca.2021.10.011_b0035","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1681\/ASN.2017010055","article-title":"Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac Surgery","volume":"28","author":"Parikh","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.cca.2021.10.011_b0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/14737159.2019.1642750","article-title":"Serum heart-type fatty acid-binding protein as a predictor for the development of sepsis-associated acute kidney injury","volume":"19","author":"Jiang","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.cca.2021.10.011_b0045","doi-asserted-by":"crossref","first-page":"16963","DOI":"10.1038\/s41598-019-53349-1","article-title":"Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score","volume":"9","author":"McBride","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2021.10.011_b0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1253\/circj.CJ-14-0653","article-title":"Serum heart-type fatty acid-binding protein level can be used to detect acute kidney injury on admission and predict an adverse outcome in patients with acute heart failure","volume":"79","author":"Shirakabe","year":"2015","journal-title":"Circ. J."},{"issue":"12","key":"10.1016\/j.cca.2021.10.011_b0055","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2217\/bmm-2017-0060","article-title":"Group analysis identifies differentially elevated biomarkers with distinct outcomes for advanced acute kidney injury in cardiac surgery","volume":"11","author":"Lin","year":"2017","journal-title":"Biomark. Med."},{"issue":"1","key":"10.1016\/j.cca.2021.10.011_b0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12872-016-0340-1","article-title":"The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit","volume":"16","author":"Shirakabe","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"issue":"6","key":"10.1016\/j.cca.2021.10.011_b0065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1373\/jalm.2016.022897","article-title":"Creation of a Universal Sample Bank for Determining the 99th Percentile for Cardiac Troponin Assays","volume":"1","author":"Wu","year":"2017","journal-title":"J. Appl. Lab. Med.: AACC Publ."},{"issue":"4","key":"10.1016\/j.cca.2021.10.011_b0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1373\/clinchem.2017.277186","article-title":"Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers","volume":"64","author":"Wu","year":"2018","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.cca.2021.10.011_b0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.2019.5774","article-title":"Reconsidering the Consequences of Using Race to Estimate Kidney Function","volume":"322","author":"Eneanya","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2021.10.011_b0080","unstructured":"L. Gary, S.A. Horowitz, C. Boyd, James, Garg Uttam, Horn Paul, Pesce Amadeo, E. Sine Harrison, Zakowski Jack, Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline - Third Edition [Guideline], 2010 October 19, 2010;28 30:72; October 2010."},{"issue":"9","key":"10.1016\/j.cca.2021.10.011_b0085","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.clinbiochem.2017.02.022","article-title":"Statistical considerations for determining high-sensitivity cardiac troponin reference intervals","volume":"50","author":"Hickman","year":"2017","journal-title":"Clinical Biochem."},{"issue":"12","key":"10.1016\/j.cca.2021.10.011_b0090","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/clinchem\/hvaa208","article-title":"Choice of Statistical Tools for Outlier Removal Causes Substantial Changes in Analyte Reference Intervals in Healthy Populations","volume":"66","author":"Hickman","year":"2020","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.cca.2021.10.011_b0095","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1253\/circj.71.1452","article-title":"Circulating Levels of Heart-Type Fatty Acid-Binding Protein in a General Japanese Population Effects of Age, Gender and Physiologic Characteristics","volume":"71","author":"Niizeki","year":"2007","journal-title":"Circulat. J."},{"issue":"4","key":"10.1016\/j.cca.2021.10.011_b0100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1258\/000456302760042173","article-title":"Evaluation of a sandwich enzyme-linked immunosorbent assay for the measurement of serum heart fatty acid-binding protein","volume":"39","author":"Pagani","year":"2002","journal-title":"Ann. Clin. Biochem.: Int. J. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2021.10.011_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/00365513.2012.734396","article-title":"Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay","volume":"73","author":"Carless","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"16\u201317","key":"10.1016\/j.cca.2021.10.011_b0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clinbiochem.2014.07.011","article-title":"Verification of an immunoturbidimetric assay for heart-type fatty acid-binding protein (H-FABP) on a clinical chemistry platform and establishment of the upper reference limit","volume":"47","author":"Da Molin","year":"2014","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.cca.2021.10.011_b0115","first-page":"441","article-title":"Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects","volume":"45","author":"Pelsers","year":"1999","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2021.10.011_b0120","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1258\/acb.2009.009055","article-title":"Serum 99th centile values for two heart-type fatty acid binding protein assays","volume":"46","author":"Bathia","year":"2009","journal-title":"Ann. Clin. Biochem.: Int. J. Lab. Med."},{"issue":"2","key":"10.1016\/j.cca.2021.10.011_b0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ehf2.12414","article-title":"Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers","volume":"6","author":"Shirakabe","year":"2019","journal-title":"ESC Heart Failure"},{"issue":"1","key":"10.1016\/j.cca.2021.10.011_b0130","article-title":"Determination of high-sensitivity cardiac troponin T upper reference limits under the improved selection criteria in a Chinese population","volume":"34","author":"Zhang","year":"2020","journal-title":"J. Clin. Lab. Analy."},{"issue":"5","key":"10.1016\/j.cca.2021.10.011_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094834","article-title":"Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study","volume":"9","author":"Otaki","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121003557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:05:13Z","timestamp":1757862313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121003557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"alternative-id":["S0009898121003557"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of 97.5th and 99th percentile upper reference limits for heart-type fatty acid-binding protein (H-FABP) in a US population","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}